Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Public Health Considerations in Ireland's Deposit Return Scheme.

Irish medical journal·2026
Same author

Low Serum Concentrations of Rifampicin and Pyrazinamide Associated with Poor Treatment Outcomes in Children with Tuberculosis Related to HIV Status.

The Pediatric infectious disease journal·2016
Same author

Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.

Antimicrobial agents and chemotherapy·2014
Same author

Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2013
Same author

Model for blood collections management.

Transfusion·2010
Same author

Stakeholder analysis for health research: case studies from low- and middle-income countries.

Public health·2010

Related Experiment Video

Updated: May 31, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

A model for blood components processing.

Harshal Lowalekar1, N Ravichandran

  • 1Operations Management and Quantitative Techniques, Indian Institute of Management Indore, Madhya Pradesh, India. harshal@iimidr.ac.in

Transfusion
|July 9, 2011
PubMed
Summary
This summary is machine-generated.

Optimizing blood component therapy is key. This study found that fully componentizing all blood may increase costs and wastage, suggesting a balanced approach for blood banks.

More Related Videos

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Related Experiment Videos

Last Updated: May 31, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Area of Science:

  • Transfusion Medicine
  • Health Services Research
  • Biotechnology

Background:

  • Blood component therapy enhances blood unit availability and reduces transfusion risks.
  • Fractionating blood into components allows multiple patients to receive specific treatments.
  • Componentization incurs increased operational costs, including processing, storage, and wastage.

Purpose of the Study:

  • To determine the optimal level of blood component production for a blood bank.
  • To balance the benefits of component therapy with operational costs and wastage.

Main Methods:

  • A simulation-based model was developed to represent a blood bank's operations.
  • The model assessed the impact of varying fresh blood fractionation levels on performance.
  • The study focused on a blood bank in southern India.

Main Results:

  • Extensive componentization of fresh blood may not be optimal for all blood banks.
  • High levels of componentization can lead to increased operational costs.
  • Significant wastage of blood products can result from over-componentization.

Conclusions:

  • The simulation methodology can be adapted to optimize componentization levels at other blood banks.
  • Inputting specific operational data allows for tailored componentization strategies.
  • Finding the optimal componentization level is crucial for efficient blood bank management.